Skip to content

Clinical Feasibility and Evaluation of Silicon Photon Counting CT

Clinical Feasibility and Evaluation of Silicon Photon Counting CT

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05838482
Enrollment
45
Registered
2023-05-01
Start date
2023-09-07
Completion date
2026-04-30
Last updated
2026-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CT Photon-Counting

Brief summary

The purpose of the study is to collect data to evaluate utility of the using photon-counting CT in a clinical setting.

Detailed description

Data collected in this study includes an assessment of image quality parameters including spatial resolution, image contrast, and noise that will evaluate the product and how this photon-counting CT technology can be used to reduce the overall radiation dose in CT imaging, and enhance clinical applications for CT technology. This data and analysis will help support regulatory submission.

Interventions

DEVICECT Photon-Counting

Enrolled subjects will complete an exam using the photon-counting CT, with or without IV contract as indicated. Images will then be compared with the previously acquired CT conducted as standard of care.

Sponsors

GE Healthcare
Lead SponsorINDUSTRY
Stanford University
CollaboratorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Who are 18 years of age or older * Able to sign and date the informed consent form * Who have in the past 120 days or will in the future 30 days undergo a clinically-indicated CT exam of the head, neck, heart, chest, abdomen, pelvis, or extremities where images are available for this prior scheduled exam

Exclusion criteria

* Who are pregnant or lactating; * Who were previously enrolled in this study; * For contrast-enhanced CT exams, anyone with known or suspected allergy to iodinated contrast agents * For contrast-enhanced CT exams, anyone with known or suspected renal insufficiency as determined by site medical personnel; * Who need urgent or emergent care; * Who have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the subject; OR * Who are unwilling to have GEHC personnel present for the CT exam.

Design outcomes

Primary

MeasureTime frameDescription
Data Collection1 yearNumber of Participants with raw investigational photon-counting CT scan data along with prior standard of care diagnostic CT exam data/images

Secondary

MeasureTime frameDescription
Image Quality1 yearReconstructed images produced from the raw investigational photon-counting CT scan will be scored for image quality using a Likert Scale (1 - Non-Diagnostic to 5 - Excellent Image Quality)

Countries

United States

Contacts

STUDY_DIRECTORBrian Thomsen

GE Healthcare

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026